Target intelligence / Profile preview

Kelch-like protein 24 (KLHL24)

Target
KLHL24
Molecular classification
E3 ubiquitin ligase substrate receptor, BTB-Kelch family protein, Adaptor protein for ubiquitination complex
01

Overview

Kelch-like protein 24 (KLHL24) is a member of the BTB-Kelch family of proteins that functions as a substrate receptor in the BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex[3][4]. In this role, it mediates ubiquitination and subsequent proteasomal degradation of specific substrates, especially intermediate filament proteins such as keratin 14 in keratinocytes, maintaining the balance of cytoskeletal stability and turnover required for skin integrity[2][3]. KLHL24 also regulates desmin and vimentin intermediate filaments, which are important for cardiac muscle and fibroblast function, respectively[1][2]. Mutations in KLHL24 that alter protein stability or function cause severe genetic diseases such as epidermolysis bullosa simplex and both dilated and hypertrophic cardiomyopathy, likely due to dysregulated turnover of its substrate filaments in the skin and heart[1][2][4]. In the nervous system, KLHL24 modulates the function of kainate-type glutamate receptors, but its primary clinical significance is in skin and cardiac disease[2][4]. Various alternative names and gene designations have been used for KLHL24, related to its functional discovery in different systems. Therapeutic strategies would theoretically target pathological ubiquitination but currently, no drugs act directly on KLHL24.

Other names
Kelch-like family member 24KLHL24DRE1KRIP6FLJ20059Kainate receptor-interacting protein for GluR6Protein DRE1CMH29EBS6EBSSHkelch-like protein 24kainate receptor interacting protein for GluR6kelch-like 24
02

Biological functions

Ubiquitin-mediated protein degradationRegulation of intermediate filament turnover (especially keratin 14)Maintenance of skin integrityModulation of kainate receptor function (neuronal regulation)Cardiac tissue development and homeostasis
03

Disease associations

Epidermolysis bullosa simplex (skin fragility disorder)Dilated cardiomyopathyHypertrophic cardiomyopathy
04

Safety considerations

Gain-of-function mutations can cause life-threatening skin fragility (epidermolysis bullosa simplex) and increased risk of early-onset cardiomyopathy with sudden cardiac death or heart failureLoss-of-function mutations can cause hypertrophic cardiomyopathy (with desmin-overload) and risk of sudden death
05

Biomarkers

Mutations in KLHL24 (notably, translation initiation codon mutations) as biomarkers for skin fragility syndromes and inherited cardiomyopathy

Beyond the preview

Go deeper on Kelch-like protein 24 (KLHL24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 24 (KLHL24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call